[P13] ポスターセッション 13　泌尿器（尿路上皮がん）

[P13-2] KEYNOTE-992: Pembrolizumab（pembro）+Chemoradiotherapy（CRT） Versus Placebo+CRT for Muscle-Invasive Bladder Cancer（MIBC）

^○Nicholas D. James¹, Jeff M. Michalski², Andrew James Weickhardt³, Michiel Simon Van Der Heijden⁴, Arjun Valant Balar⁵, Shahrokh F. Shariat⁶, Xiao Fang⁷, Ekta Kapadia⁷, Neal D. Shore⁸ (1.Institute of Cancer Research, The Royal Marsden Hospital NHS Foundation Trust, 2.Washington University School of Medicine in St. Louis, 3.Olivia Newton-John Cancer Wellness & Research Centre, 4.Netherlands Cancer Institute, 5.Perlmutter Cancer Center, NYU Langone Health, 6.Medical University of Vienna, 7.Merck & Co., Inc., 8.Carolina Urologic Research Center)